J&J Settles Risperdal Lawsuit on Opening Day of Trial

Johnson & Johnson settled a lawsuit on the first day of a trial over claims its antipsychotic drug Risperdal (risperidone) caused a male plaintiff to grow breast tissue, one of his lawyers told a state judge in Philadelphia.
Bloomberg